Aquestive Therapeutics, Inc.AQSTNASDAQ
LOADING
|||
Analyst Sentiment
Analysts lean bullish — 100% recommend buying.
Consensus Rating
Buy
10 analysts·Moderate coverage
100%
Rating Distribution
Strong Buy
00%
Buy
10100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Analysts see significant upside — consensus target 193% higher.
Bear Case
$12.00
+193%
Consensus
$12.00
+193%
Bull Case
$12.00
+193%
Price Range10 analysts
Low
Consensus
High
$12.00
$12.00
Current Target
Current Price
$4.10
Upside to Target
$7.90
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.